Mechanistic insights from the crystal structures of a feast/famine regulatory protein from Mycobacterium tuberculosis H37Rv by Shrivastava, Tripti & Ramachandran, Ravishankar
7324–7335 Nucleic Acids Research, 2007, Vol. 35, No. 21 Published online 25 October 2007
doi:10.1093/nar/gkm850
Mechanistic insights from the crystal structures
of a feast/famine regulatory protein from
Mycobacterium tuberculosis H37Rv
Tripti Shrivastava and Ravishankar Ramachandran

Molecular & Structural Biology Division, Central Drug Research Institute, P.O. Box 173, Chattar Manzil,
Mahatma Gandhi Marg, Lucknow-226001, India
Received August 9, 2007; Revised September 25, 2007; Accepted September 26, 2007
ABSTRACT
Rv3291c gene from Mycobacterium tuberculosis
codes for a transcriptional regulator belonging
to the (leucine responsive regulatory protein/regu-
lator of asparigine synthase C gene product) Lrp/
AsnC-family. We have identified a novel effector-
binding site from crystal structures of the apo
protein, complexes with a variety of amino acid
effectors, X-ray based ligand screening and quali-
tative fluorescence spectroscopy experiments. The
new effector site is in addition to the structural
characterization of another distinct site in the
protein conserved in the related AsnC-family of
regulators. The structures reveal that the ligand-
binding loops of two crystallographically indepen-
dent subunits adopt different conformations
to generate two distinct effector-binding sites.
A change in the conformation of the binding site
loop 100–106 in the B subunit is apparently neces-
sary for octameric association and also allows the
loop to interact with a bound ligand in the newly
identified effector-binding site. There are four sites
of each kind in the octamer and the protein
preferentially binds to aromatic amino acids. While
amino acids like Phe, Tyr and Trp exhibit binding to
only one site, His exhibits binding to both sites.
Binding of Phe is accompanied by a conformational
change of 3.7A ˚ in the 75–83 loop, which is
advantageously positioned to control formation of
higher oligomers. Taken together, the present
studies suggest an elegant control mechanism for
global transcription regulation involving binding of
ligands to the two sites, individually or collectively.
INTRODUCTION
Mycobacterium tuberculosis is a successful pathogen
mainly because of its ability to persist in the human
host for several years while evading the immune system
(1). The rv3291c gene codes for an Lrp/AsnC (leucine
responsive regulatory protein/regulator of asparigine
synthase C gene product) type global transcriptional
regulator (MtbLrp) (2) and belongs to the large family
of DNA-binding transcriptional regulators. It has been
suggested that Lrp/AsnC type proteins should more
appropriately be called feast/famine regulatory proteins
because of their involvement in regulation of metabolic
pathways in response to the availability of amino acids
and nitrogen bases in the external environment (3,4).
These proteins are also involved in DNA bending,
condensation of DNA into globular nucleo-protein
structures, chromosome structure and organization,
among other roles (3,5).
Individual subunits of these proteins have a molecular
weight of 17kDa and are divided into two domains
namely DNA and eﬀector-binding domains which
occur at the N- and C-terminal regions, respectively.
The DNA-binding domain contains the helix-turn-helix
motif while the eﬀector-binding domain is also involved
in oligomeric interactions. Higher order assemblies usually
exist as multiples of dimers and include formation of
tetramers, octamers, dodecamers and chromatin-like
cylinders (5–9). How these proteins translate the eﬀector-
binding event to the protein–DNA-binding site is
unclear. Some global regulators like the Escherichia coli
Lrp, which reportedly controls over 10% of all genes,
are known to bind to a variety of amino acids including
leucine, alanine, valine, proline and lysine, whose binding
can eﬀect a positive/negative regulation of the target genes
(5,10). On the other hand, local regulation involving
proteins like AsnC, is controlled by the binding of a
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It has been suggested that binding of appropriate ligands,
primarily amino acids, can eﬀect functionally relevant
tertiary structure conformational changes or to oligomeric
association. Thus a small number of such regulators
found in archaea and bacteria can regulate a large number
of genes in response to the environmental changes (4).
Consistent with this, rv3291c has a molecular weight of
18kDa and has been found to be up-regulated 15-fold
in nutrition starved tuberculosis models designed to mimic
the latent/persistent state (13). Our earlier sequence
analysis and initial characterization (14) suggested that
it belongs to the Lrp-family of regulators. It lies in
the genomic region upstream of sigF involved in
mycobacterial stress response (15) and its expression has
also been observed on inhibition of septum formation
and is inversely proportional to bacterial growth rate
(16,17). More recently, in Mycobacterium fortuitum,
the homologous gene was been found to be highly
conserved and in vivo screening involving a murine
infection model of persistence using this pathogen led to
the identiﬁcation of a mutant where this gene was
disrupted. It was found that the mutation aﬀected
the ability of the pathogen to persist in the kidney in the
model (personal communication, Dr R. Srivastava,
Central Drug Research Institute, Lucknow, India).
The above data suggest that the protein is important
for maintenance/adaptation to long-term persistence
although it is not essential for growth under normal
conditions (18). Rv3291c therefore has the potential to be
an important therapeutic target for developing strategies
to counter persistence of the disease.
Structurally characterized examples of the Lrp/AsnC-
family of transcription regulators includes the E. coli
Lrp (19), E. coli AsnC complexed to asparigine (20),
Neisseria Meningitides Lrp complexed to leucine and
methionine, respectively (21), Bacillus subtilis LrpC and
related archaeal regulators LrpA from Pyrococcus furiosus
and P. sp OT3 FL11 (3,11,12,22–24). A comparison of
the changes that occur upon eﬀector binding could not be
addressed in the AsnC structure due to the absence of
the apo structure. The complexes with the N. meningitides
regulator did not reveal signiﬁcant changes to tertiary
structure on amino acid binding. A sequence analysis
of Lrp and AsnC type regulators show that the protein
sub-families exhibit larger diﬀerences in the C-terminal/
eﬀector binding domain with an overall sequence identity
of 25% (14,20) reﬂecting diﬀerences in eﬀector
binding between the protein sub-families.
Many aspects of structure and function-like variations
in individual regulation mechanism are currently
unclear; as also how ligand binding aﬀects interactions
with DNA and whether ligand binding eﬀects signiﬁcant
changes to the tertiary structure. In the initial part of
this work we report the X-ray structure of the apo
MtbLrp solved through MIRAS methods. The protein
associates as a tetramer of dimers to form an octamer.
Fluorescence spectroscopy and X-ray co-crystal structures
show that MtbLrp binds to a variety of amino acids.
We used X-ray screening-based approaches to determine
that the protein preferentially binds to aromatic
amino acids and also were able to rank their order
of preference. In the present structures we have identiﬁed
a new small molecule-binding site at the dimer interface
(called ‘type II’) in addition to the previously reported
eﬀector-binding site in the related E. coli AsnC and
N. meningitides Lrp complexes (called ‘type I’). Both sites
apparently have diﬀerent preferences for ligand molecules.
While amino acids like Phe, Leu and Trp bind to the site
previously reported in the E. coli AsnC regulator,
His binds to both sites in MtbLrp. The ligands occupy
only 4 out of 8 possible sites of type I in contrast to full
occupancy in the earlier reported complexes. There is a
change in the binding site loop conformation in the
unoccupied type I sites which lets the same loop interact
with the bound histidine in type II binding sites while
preventing ligand binding at site I. Taken together, the
present studies suggest an elegant control mechanism
for global transcription regulation involving binding of
ligands to the two sites, individually or collectively.
MATERIALS AND METHODS
Overexpression and purification
Rv3291c was cloned, expressed and puriﬁed as reported
earlier (14). Brieﬂy the PCR-ampliﬁed construct was
ligated into pET21d (M/s Novagen) vector between the
NcoI and HindIII sites. His-tagged protein, with the tag
at the C-terminal end, was puriﬁed by standard proce-
dures after transforming the plasmid into BL21 (DE3)
cells. The protein was concentrated to 20mg/ml in
50mM Tris–HCl pH 8.0, 50mM NaCl and 5mM EDTA
after size exclusion chromatography using Superdex-200
HR 10/30 (M/s Amersham). Protein concentrations were
determined as per the Bradford method (25).
Crystallization, datacollection and structure determination
The protein was crystallized using the hanging drop
technique by equilibrating protein drops against reservoirs
containing 100mM MES pH 6.0, 0.75M lithium
acetate at 228C. Heavy atoms were screened by band
shift assays on a native gel. Crystals were soaked
in appropriate heavy atom solutions for varying times
and concentrations. Data were collected using a Rigaku
RU300 X-ray generator coupled with MAR345 detector
or alternatively with MAR345-DTB detector on crystals
mounted in quartz capillaries at room temperature.
Data were processed using MOSFLM (26) implemented
in the CCP4 package (27) and collection parameters are
summarized in Supplementary Table 1. While crystals of
the apo protein diﬀract to 2.5A ˚ resolutions, the crystals of
the Phe complex diﬀract to 2.2A ˚ .
Extensive molecular replacement calculations using
available archaeal and bacterial Lrp structures were
inconclusive. Phases were therefore calculated by
MIRAS methods using the SOLVE/RESOLVE package
(28–30) using three derivatives; the ﬁrst one being
silver nitrate, (crystals soaked in 80mM solution for
2 days) and the latter two data sets from potassium tetra-
chloro-platinate (2.0mM, overnight soak) and cadmium
iodide (1.7mM, 1h soak) derivatives. The solution output
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solvent ﬂattening and this went up to 0.68 after
density modiﬁcation and phase extension using
RESOLVE. The structure solution parameters are sum-
marized in Supplementary Table 1a. RESOLVE could
trace 15% of the residues. The map quality was
suﬃcient to trace the remaining chains manually using
TURBO–FRODO (31). Reﬁnements were carried out
using REFMAC (32) after setting aside 10% of the
reﬂections for monitoring the free R-factor. Structures of
the complexes were solved using diﬀerence Fourier
techniques. Omit maps were examined to avoid bias.
Quality of the structures was checked using PROCHECK
(33) and the geometric parameters as also the
Ramachandran plot (34) falls into acceptable ranges.
X-rayscreening forligands
Crystals were grown under above conditions, except
that an amino acid mixture corresponding to 2mM
each of the following amino acids namely Phe, His, Leu,
Trp, Met and Tyr, were added to the crystallization drop.
The best binding amino acid was identiﬁed after each
round of data collection and structure solution. The next
rounds of crystallization were carried out serially using
only the remaining compounds.
Qualitative fluorescence spectroscopy studies
A qualitative analysis of the amino acid binding was
carried out using competitive displacement of ANS
(1-Anilino-8-naphthalene-sulfonate) from the protein by
the respective ligands (35). A Perkin-Elmer Life Sciences
LS 50B ﬂuorescence spectrophotometer was used in
the experiments at 258C. The excitation wavelength used
was 380nM and the emission was monitored between 400
and 600nM, respectively. Excitation and emission slit
widths were kept at 7nM, respectively. All samples were
incubated for 2h under speciﬁed conditions before
recording the spectra. Initially the protein (1mM) was
titrated against 0–50mM ANS to determine its optimal
concentration for subsequent experiments. In the displace-
ment experiments 1mM of protein incubated with 10mM
ANS was titrated with 0–25mM of respective ligands.
An inhibitor namely cyclohexylmethyl amine derivative,
of Lysine  -aminotransferase (36), a totally unrelated
protein, was used as a control compound which should
not exhibit any binding to the protein.
Analysis
Analysis of the inter-subunit contacts and ligand–protein
interactions, accessible surface area, etc. were carried
out using CONTACTS and other tools implemented
in the CCP4 package (27). Structural superposition
was carried out using ALIGN (37) and PROFIT (http://
www.bioinf.org.uk/software/proﬁt). Figures were gener-
ated using Pymol (38), CCP4MG (39) and InsightII
(http://www.accelrys.com/products/insight).
RESULTS
Structure description
The protein was puriﬁed as reported earlier (14). The size
of the protein was consistent with a stable octameric
association in size exclusion chromatography experiments.
Extensive molecular replacement calculations using the
coordinates of previously reported archaeal Lrp structures
were unsuccessful. We consequently used MIRAS app-
roaches to solve the structure of the protein (Figure 1a).
Structure solution and data collection statistics are given
in Supplementary Table 1a. There are two independent
subunits in the asymmetric unit, which form a dimer
(Figure 1b). This dimer subsequently forms an octamer
through crystal symmetry (Figure 1c). Each subunit of
rv3291c (MtbLrp) folds into two distinct domains joined
by a rather long linker as observed in other structural
examples of this family (20,23,24). The N-terminal domain
is the DNA-binding domain which initially forms a helix
(residues 6–17) and subsequently folds into an helix-turn-
helix motif (residues 24–48) observed earlier also in other
structures from this protein family (4) (A structure-based
sequence alignment is in Supplementary Figure 1).
A rather long linker (residues 48–60) consisting of a
b-strand and a helical stretch then brings the chain to the
eﬀector-binding domain. This latter domain is involved
extensively in oligomeric interactions and contains four
b-strands and two a-helices arranged in a babbab topol-
ogy (between residues 66 and 137). The chain ends in
a b-strand (residues 139–143), which interacts with the
b2 strand of the dimeric counterpart to form a ﬁve-
stranded curved sheet in the dimer.
Oligomeric association
The two independent subunits in the apo structure
superpose onto each other with r.m.s.d. of 0.74A ˚ for all
Ca atoms and reveals conformational diﬀerences in two
loops; the ﬁrst being the loop linking the initial b- and
a-motifs (residues 75–83) of the eﬀector-binding domain
and the other forming part of the small molecule binding
site (residues 100–105) (Figure 1a). The maximum
displacements of 3.4 and 1.7A ˚ are centered at Ser79 and
Glu103, respectively. When the subunits were superposed
onto each other in the oligomer it became clear that
the conformational changes are necessary for octamer
association as otherwise it would lead to unacceptable
steric contacts. The respective DNA-binding domains of
each subunit of the octamer face the outside of the tightly
packed oligomeric structure. This is in line with its
observed role in formation of nucleo-protein structures
and packaging of DNA (20,24). The domain exhibits
a higher than average displacement of 1A ˚ after
superposition for residues 24–48.
Structures of complexes with aminoacids
We initially co-crystallized the protein with Se-Met to
identify the eﬀector-binding site unambiguously in
MtbLrp. Clearly the binding sites for this molecule
were spatially conserved with the E. coli AsnC and
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amino acid complexes are available (20,21). We then
co-crystallized the protein with a variety of amino
acids including Leu, Arg, Gln, Thr, Phe, Tyr, Trp, Pro,
Met and His. Unambiguous density for bound ligand
was found in the structures with Phe, His, Tyr, Trp
and Met (in addition to Se-Met which was used to
identify the binding site) (Figure 2, Supplementary
Figure 2). In the remaining structures including
that with Leu, weaker density was observed. Data
collection and reﬁnement statistics of the respective
complexes are in Supplementary Table 1b.
(a)
(b)
(c)
Figure 1. (a) Crystal structure of MtbLrp. The two crystallographically independent subunits have been superposed and the Ca trace is depicted.
Selected residues are labeled and the ﬁgure is shown in stereo. (b) The association of the subunits into a dimer. The two chains have been colored
‘blue’ and ‘golden’ respectively. (c) Octameric association in MtbLrp generated by crystal symmetry. The chains of the octamer have been colored
distinctly for clarity.
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Well-deﬁned density for Phe at a resolution of 2.2A ˚
(Figure 2a), allows for a detailed analysis of the ligand–
protein interactions. The ligand-binding site is partially
formed by residues 100–106 of subunit A containing
a conserved Gly (Gly 102 in MtbLrp) and also residues
from symmetry related subunits in the octamer. This Gly is
a conserved sequence feature in the respective binding sites
of ACT/RAM domain containing proteins (20). Figure 3a
shows a close-up of the interactions of Phe in its complex
which is also tabulated (Supplementary Table 2a). The
binding site is at an inter-dimer interface and comprises of
residues from diﬀerent subunits. In contrast to earlier
complexes (20,21), only 4 sites out of 8 possible ligand-
binding sites were occupied and binding to the other sites
was precluded due to the conformational changes
discussed above. The side chain of the ligand is stabilized
mainly by ‘van der Waals’ interactions including those
with Arg126, Tyr106, Asp82, Ser105 and Ser99. The main
chain carboxylate atoms of Phe are stabilized by polar
interactions involving Ser135 OG and N atoms. Thr135
OG also interacts with a main chain carboxylate atom of
Phe. The main chain O and N atoms of Gly102, the
conserved binding site residue mentioned above, interacts
with the main chain N and carboxylate atoms of the
ligand. Main chain N of the bound ligand also forms
hydrogen bonds with the main chain O of Val100 and
Glu104, respectively. The same ligand atom interacts with
Ser105 OG and Glu103 N respectively through a water
molecule. The same water molecule interacts with another
binding site of water associated with symmetry-related
Thr133 N and O atoms. Thus a network of polar
interactions, which also involve symmetry-related atoms
in the octamer stabilizes the bound ligand.
The binding of Phe is accompanied by a change in
the conformation of loop 75–83 of subunit A (Figure 3b).
In fact the maximum main chain displacement of 3.7A ˚
occurs at the Ca atom of the Pro81 residue. On the other
hand, the spatial disposition of loop 100–106 of
the subunit as also that of the helix-turn-helix motif at
the N-terminal domain are relatively unaﬀected by
binding of the ligand.
His complex
The structure of the His complex resulted in the
identiﬁcation of a novel ligand-binding site in addition
to the site occupied by Phe in its co-crystal structure.
The eﬀector has unambiguous density at both sites
allowing for an analysis of the protein-His contacts in
the complex (Figure 2b). The interactions of the main
chain atoms of His with the protein at site I is similar to
that of bound Phe with the main chain N and carboxylate
atoms interacting with residues in the 100–106 loop
and also with Thr133 and Ser135 of a neighboring subunit
in the octamer (Figure 3c and Supplementary Table 2b).
Additional interactions in this complex include those of
ND1 atom of the side chain with Ser105 of the same
subunit and with Arg126 of a neighboring subunit in
the octamer. The nitrogen atoms of the side chain also
interact with the latter arginine residue through a water
molecule.
The type II binding site occurs at the intra-dimer
interface. This site forms part of a hydrophobic core in
the protein. In the apo structure as also in the other amino
acid complexes two to three water molecules have a spatial
disposition similar to that of the imidazole ring of His
in this site. The main chain carboxylate atoms of bound
His in this site interact with Glu B103 and B104 residues
(Figure 3d). These latter residues form part of the
binding site loop in the unoccupied type I sites in the
octamer. The N atom of the main chain interacts with
Arg A134. The ND1 and NE2 atoms of the side chain
extensively interact with Thr B136 and Arg A134 through
water bridges. The main chain atoms of the bound ligand
interact with Arg134 from both subunits through water-
mediated interactions as also with Thr B136 and Glu B103.
Other residues within 4A ˚ of the ligand include Phe70 from
(a)
(b)
Figure 2. Stereoview of the electron density maps at (a) binding site I in
the MtbLrp–phenylalanine complex and (b) binding site II in the
MtbLrp–histidine complex. The 2FoFc maps have been contoured at
1  level and depicted as a ‘blue’ mesh. Selected residues around the
binding site have been shown and selected atoms labeled. Atoms are
colored as per convention and water oxygens are shown as ‘red’
spheres. The ﬁgure was generated using CCP4MG (39).
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imidazole ring of the bound ligand. The protein–His
interactions are tabulated in Supplementary Table 2b.
Tyr, Trp, Met, Leu and other complexes
The main chain interactions of Tyr in its complex are
expectedly similar to those described earlier. Figure 4a
contains a schematic of the interactions of the Tyr with
the protein. The OH atom of its side chain exhibits
polar interactions with Asp A82, Tyr B106
 and Arg
B126
. The latter two residues belong to the neighboring
subunits in the octamer; incidentally the Tyr residue
is part of the binding site loop in the unoccupied type I
sites. On the other hand, Asp is part of the loop exhibiting
maximum movement in the Phe complex.
In the Trp complex the indole side chain of the ligand
mainly exhibits ‘van der Waals’ interactions with the
protein (Figure 4b). Surprisingly, no polar interaction
with the nitrogen atom in the side chain was observed in
the structure. On the other hand the SD atom of the
methionine side chain interacts with Arg 126 of a
neighboring subunit in its complex (Figure 4c). In the
latter structure also a change in the conformation of
the loop 75–83, albeit to a lesser extent than in the Phe
complex was observed. Interactions of the respective
ligands are tabulated in Supplementary Table 2. The
above three ligands also have clearly deﬁned side chain
electron density in the maps (Supplementary Figure 1).
The close-up of leucine in its complex with MtbLrp
and interaction details is in Figure 4d and Supplementary
Table 2f, respectively. Leu mainly interacts with
the protein through its main chain atoms. The side chain
is quite ﬂexible as shown by the lack of clear density for it
beyond the Cb atom and exhibits only non-bonded
interactions with the protein. A similar situation
(a) (b)
(c) (d)
Figure 3. (a) Interactions of phenylalanine in its complex with MtbLrp. Protein is shown in cartoon representation. Hydrogen bonds are indicated by
black dotted lines. Selected binding-site residues are labeled and plotted in stick representation. Water molecules are indicated by red spheres. Atom
coloring is as per convention except that carbon atoms of bound Phe (stick representation) are shown in ‘green’ while those of interacting subunits
are shown in ‘orange’ and ‘yellow’ respectively. (b) Movement of loop 75–83 by 3.7A ˚ after binding of phenylalanine. The apo and complexed
proteins are in ‘cyan’ and ‘orange’ respectively while the direction of the movement is indicated by an arrow. Selected residues are labeled. Bound
ligand is depicted in ‘stick’ representation while structural water is depicted as ‘orange’ spheres. (c) Interactions of histidine with MtbLrp at site I.
Color conventions and representations in this and the subsequent ﬁgure are as in (a) above. (d) Interactions of histidine at site II in MtbLrp.
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with which co-crystals could be obtained and the electron
density maps reveal weak density at the position of the
main chain atoms seen in the earlier structures (data not
shown). It was therefore concluded that these amino acids
exhibit weak binding to the protein.
X-raybasedligand screening
In an eﬀort to identify the amino acids for which the
protein has a natural aﬃnity, we used X-ray based
ligand screening as a tool where small molecules, which
have the highest aﬃnity for the protein are competitively
selected from the crystallization solution. These screening
techniques are sensitive in detecting and diﬀerentiating
between even weakly binding small molecule fragments
to a protein (40). We used this technique to characterize
relative binding aﬃnities of diﬀerent amino acids to
MtbLrp. Accordingly we crystallized the protein
from a solution containing amino acids which
showed well-deﬁned density for at least the main chain
and Cb atoms in their respective co-crystal structures.
The solution initially contained Leu, Phe, Tyr, Trp, Met
and His. Crystals from the ﬁrst round of experiments had
unambiguous density for Phe, which was additionally
conﬁrmed by observing the displacement of the 75–83
loop observed in its complex. In the next round of
screening, Phe was removed from the crystallization
solution and this time His was identiﬁed from the electron
density maps. This was aided by the fact that His is the
only amino acid in this set that binds to type II sites also.
Tyr and Trp formed co-crystals in subsequent screening
experiments followed by Met. Identiﬁcation of the
respective ligands from the electron density maps was
straightforward as we could also compare the densities
with those obtained earlier from single co-crystallization
experiments. Thus the relative binding aﬃnities were
identiﬁed to be Phe>His>Tyr>Trp> Met>(Leu, others).
MtbLrp was therefore deduced as having a preference for
aromatic amino acids.
Qualitative fluorescence spectroscopy
We used competitive displacement of ANS by compounds
being tested to qualitatively check the binding of the
(a) (b)
(c) (d)
Figure 4. Interactions of (a) Tyrosine, (b) Tryptophan, (c) Methionine and (d) Leucine in their respective site I complexes with MtbLrp. The coloring
and representation of interacting atoms and ligand are as in the earlier ﬁgures.
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acids led to reduction in the observed ﬂuorescence of
bound ANS. An inhibitor, namely a cyclohexylmethyl
amine derivative, of a completely unrelated protein, lysine
 -amino transferase whose structure was reported by us
recently (36) was used as a control compound, which
should not bind to MtbLrp. As mentioned above, the
binding exhibited by leucine can be rationalized by its
co-crystal structure where only the main chain atoms are
involved in binding to the protein. The spectroscopy
results clearly support binding by a variety of amino
acids. Taken in conjunction with the X-ray screening
experiments, the results clearly demonstrate that MtbLrp
preferentially binds aromatic amino acids.
DNA binding and regulation
Earlier studies involving in silico modeling and solution
studies with DNA (23), as also modeling with the current
structure (Figure 6a) clearly suggests that DNA has to
be bent for interactions with this family of regulators (41).
The smallest functional unit of the protein is the dimer
and we have modeled its mode of DNA interactions
analogous to that reported earlier in the B. subtilis LrpC
and E. coli AsnC structures (20). It can be conceptualized
that multiple binding sites separated by non-binding
regions in the DNA stretch can be threaded around
the oligomer to form chromatin-like structures which have
been observed earlier (42,43). The stable octameric
association observed in the E. coli AsnC–asparigine
complex and B. subtilis LrpC structures, diﬀerences in
the diameters of the octamers of the bacterial and archaeal
LrpA, along with an analysis of reported binding sites
in the promoter region led the authors to suggest a model
where adjacent Lrp octamers could wrap DNA into a
solenoid-like structure (20). When we map the change in
the conformation of the loop 75–83 in the presence of
(a) (b)
(c) (d)
Figure 5. Competitive displacement of ANS by (a) Phenylalanine, (b) histidine, (c) tryptophan and (d) cyclohexylmethylamine derivative compound
used as a non-binding control. Change in ﬂuorescence was monitored by titrating the protein (1 mM)-ANS (10 mM) premix against 5, 10, 15, 20 and
25mM concentrations of each compound in the respective experiments. Arrows indicate the change in ﬂuorescence intensity upon titration. While the
amino acids exhibit binding to the protein, the control compound did not exhibit any binding.
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an advantageous spatial disposition in the octamer to
disrupt interactions with adjacent oligomers in the
proposed model (Figure 6b and c). This role for bound
ligands at site I agree with earlier co-crystal structures with
E. coli AsnC and N. meningitides Lrp where binding of
ligands to the site did not disrupt the octameric assembly.
It also agrees with solution studies in E. coli Lrp, in which
leucine-induced dissociation of hexadecamers into leucine-
bound octamers by binding to a second distinct site
(44). On the other hand, interactions of a ligand with the
newly identiﬁed site II can lead to a breakdown in octamer
symmetry as detailed in the ‘Discussion’ section.
DISCUSSION
In the present work, we have structurally characterized a
global regulator from M. tuberculosis, which promises
to be a novel target in developing therapies against
persistence of the disease. The crystal structures of the
complexes and X-ray based ligand-screening techniques,
supported by the ﬂuorescence spectroscopy results demon-
strate that rv3291c has a strong preference for aromatic
amino acids and suggests an important role in the
metabolism of the latter. It is interesting that the
MtbLrp preferentially binds aromatic amino acids while
other characterized Lrp proteins prefer eﬀectors like
Val, Leu, Ala, etc. (5,10). Aromatic amino acids are
known to be important for the viability of the pathogen
(45). In fact the enzymes in the Shikimate pathway, which
is important for aromatic amino acid metabolism, have
been recognized as important targets for anti-bacterial
therapies (46).
Importantly, the present structures have led to
the identiﬁcation of a novel small molecule-binding site
II at the protein intra-dimer interface. There are four
possible sites of this kind in the octamer (a tetramer of
dimers, Figure 7a and b) and all sites are occupied in
the structure with L-histidine. It is quite possible that
other small molecules can also bind to the site. In fact
histidine exhibits extensive water-mediated interactions
with the protein and this structural water can be
displaced to accommodate a bigger ligand also. It seems
unlikely that eﬀector molecules will disrupt the dimeric
association; on the other hand a bound ligand at this site
might eﬀect small changes to the relative spatial disposi-
tion of the DNA-binding domains (Figure 7e). These
changes will be ampliﬁed in the octamer and can lead
to either strengthening/weakening of interaction with
DNA. It may also be recalled that the binding site loop
100–106 of the B subunit interacts with the main chain
atoms of His in its complex both directly and through
water-mediated interactions. The conformation change
observed in this loop is essential for octameric association
in MtbLrp. It is therefore conceivable that a bound
(a)
(b)
(c)
Figure 6. (a) Model of DNA binding to MtbLrp dimer. B-form DNA
was taken from PDB 1CGP and adjusted using the program InsightII
(M/s Accelrys) to ﬁt the dimer. The DNA clearly has to be bent to
interact with the protein. (b) Close-up of the arrangement of bound
phenylalanine at site I (indicated by a ‘golden’ arrow) in its interactions
with the protein octamer. Gly 102 in empty type I sites (indicated
by a ‘blue’ arrow) are shown in ball-and-stick representation.
Asp82 that forms part of the 75–83 loop, which moves by 3.7A ˚ on
binding to the ligand is also indicated by ‘golden’ ball-and-sticks in
the subunit with bound Phe.( c) Schematic of DNA wrapped around
MtbLrp octamers placed side by side to form a solenoid-like
arrangement. This class of proteins is known to form stable protein–
DNA complexes like the nucleosome (43) and it is interesting that the
diameter of the octamer is 115A ˚ which is close to the nucleosome
diameter of 110A ˚ . The schematic is as per earlier experiments (43)
and in silico modeling in B. subtilis LrpC (20). In this arrangement, the
movement (indicated by double arrows) of the 75–83 loop (colored
‘red’) on ligand binding can control protein–DNA interactions and
higher oligomeric association although the octameric structure is not
disturbed.
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(b)
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Figure 7. Binding of ligands at site II in MtbLrp. (a) Octameric association in the MtbLrp–His complex. The region marked by a box is zoomed into
(b) which shows details of histidine binding in its complex with the protein. Bound ligand in type I sites are depicted in ‘green’ sticks (indicated by a
‘golden’ arrow) while those bound to type II sites are in ‘black’ sticks (indicated by a ‘black’ arrow). A ‘blue’ arrow indicates the binding site loop,
which can be ‘pushed’ out to distort the oligomeric association. Binding of ligand to only two sites can lead to the ‘open’ octamer arrangement seen
in (c) E. coli Lrp structure (PDB 2GQQ) or also be the basis for a transformation into (d) a helical cylinder-like arrangement seen in P. furiosus sp
OT3 Lrp (PDB 1RI7). Binding of ligands to this site are also advantageously situated to disturb (e) the spatial disposition of the DNA-binding
domains.
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octamer symmetry. Binding of a ligand to all four type II
sites would then lead to disassociation of the octamer into
lower oligomers (Figure 7). However, binding of a ligand
to only two sites on adjacent dimers will break the
octamer symmetry analogous to that observed in the
recent E. coli Lrp-DNA co-crystals (19) where the octamer
opens up in the presence of DNA into an open array
(Figure 7c). Such a change in oligomeric symmetry could
also form the starting point for the transition from
octameric disks to a helical cylinder (Figure 7d) observed
in the pyrococcus OT3 Lrp (24).
The other eﬀector-binding site (I) occurs at the inter-
dimer interfaces in the octamer. There are therefore
eight such possible binding sites (Figure 6b), out of
which only four are accessible to a ligand. It is possible
that these other sites may be occupied under diﬀerent
quaternary structural states observed in the class of
proteins (19–21,23,24). In contrast, bound ligands were
observed in all eight type I sites in the E. coli AsnC and
N. meningitides Lrp structures. In fact in the latter
structure, it was found that binding of leucine and
methionine led to further stabilization of the octamer.
In the present Phe complex a maximal conformational
displacement of 3.7A ˚ was observed in the 75–83 loop and
to a smaller extent in some of the other complexes.
An important role for ligands bound at this site could
therefore be in controlling higher oligomeric associations
like the one suggested in Figure 6c.
It is interesting that residues of the binding site
loop 100–106 of the unoccupied type I sites interact
with bound His in type II sites in its complex. This
strategy presumably allows for additional control of the
oligomeric state of the protein through eﬀector binding or
ﬁne-tuning of individual regulatory functions. Solution
studies involving E. coli Lrp and a couple of its mutants
(Asp113Glu & Leu135Arg), which prevent octamer–
hexadecamer transition, also revealed two kinds of sites
(44). Binding of leucine to a low aﬃnity site induced
dissociation of hexadecamers in the unmutated protein
to octamers; on the other hand, the octameric form and
the mutants retained high aﬃnity for leucine. Structural
mapping of the mutations onto the subsequently reported
E. coli Lrp structure (19) suggests that the second weak-
binding site is in a diﬀerent inter-subunit interface
compared to the type I and type II sites discussed in this
work. The Asp113Glu mutation maps onto the 100–106
loop of MtbLrp and along with symmetry related E. coli
Leu135 residue apparently generates a new site. On the
other hand, it is likely that the high aﬃnity site in E. coli
Lrp corresponds to type I sites discussed here as binding
of Leu to this site does not aﬀect the octamer assembly.
The above discussion suggests an unanticipated important
role for the binding site loop (100–106 in MtbLrp)
residues where they are involved in interacting with
ligands in the three types of sites.
In conclusion, the present study has revealed a novel
eﬀector-binding site in the MtbLrp regulator. The large
change in the disposition of the 75–83 loop by 3.7A ˚ is
also the ﬁrst seen in this regulator family upon ligand
binding. The octameric association observed in MtbLrp is
possible because of the change in the binding loop
conformation in subunit B and this has probably evolved
in order to interact with ligands in site II. We are only
now beginning to understand the immense complexity of
the regulation mechanisms employed by feast/famine
regulatory proteins. Broad structural similarities and
DNA recognition modes are apparently further ﬁne-
tuned by individual proteins by incorporating novel
eﬀector-binding sites, (the present study) and smaller
changes in structure, as seen in the MtbLrp–Phe complex,
to perform their regulatory roles.
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